Atlas Trials

FX-322 in Adults With Severe Sensorineural Hearing Loss

Clinical trial NCT04629664 · COMPLETED

Trial details

NCT number
NCT04629664
Sponsor
Frequency Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hearing Loss, SensorineuralNoise Induced Hearing LossSudden Hearing Loss
Start date
2020-11-02
Primary completion
2021-05-26
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.